Small molecule inhibitors promote efficient generation of induced pluripotent stem cells from human skeletal myoblasts

Stem Cells and Development

Volumn 22, Issue 1, 2013, Pages 114-123

  Trokovic, Ras ^a   Weltner, Jere ^a   Manninen, Tuula ^a   Mikkola, Milla ^a   Lundin, Karolina ^a   Hämäläinen, Riikka ^a   Suomalainen, Anu ^a,b   Otonkoski, Timo ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; BUTYRIC ACID;

ADULT; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; HUMAN; HUMAN CELL; INFANT; MALE; MYOBLAST; PLURIPOTENT STEM CELL; PRIORITY JOURNAL;

ADULT; ANIMALS; ANTIGENS, DIFFERENTIATION; BENZAMIDES; BUTYRIC ACID; CELL CULTURE TECHNIQUES; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CULTURE MEDIA; DIOXOLES; FEMALE; GENE SILENCING; HISTONE DEACETYLASE INHIBITORS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INFANT; INFANT, NEWBORN; MALE; MICE; MICE, NUDE; MIDDLE AGED; MUSCLE, SKELETAL; MYOBLASTS, SKELETAL; RETROVIRIDAE; SENDAI VIRUS; SIGNAL TRANSDUCTION; TERATOMA; TRANSDUCTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; YOUNG ADULT;

SENDAI VIRUS;

EID: 84871421686     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0157     Document Type: Article

References (37)

1. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676. (Pubitemid 44233629)
2. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, R Stewart, Slukvin, II and JA Thomson. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
3. Okita K, M Nakagawa, H Hyenjong, T Ichisaka and S Yamanaka. (2008). Generation of mouse induced pluripotent tem cells without viral vectors. Science 322:949-953.
4. Yu J, K Hu, K Smuga-Otto, S Tian, R Stewart, II Slukvin and JA Thomson. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science 324: 797-801.
5. Kim D, CH Kim, JI Moon, YG Chung, MY Chang, BS Han, S Ko, E Yang, KY Cha, R Lanza and KS Kim. (2009). Generation f human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4:472- 476.
6. Fusaki N, H Ban, A Nishiyama, K Saeki and M Hasegawa. (2009). Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 85:348-362.
7. Woltjen K, IP Michael, P Mohseni, R Desai, M Mileikovsky, R Hamalainen, R Cowling, W Wang, P Liu, et al. (2009). piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458:766-770.
8. Aasen T, A Raya, M Barrero, E Garreta, A Consiglio, F Gonzalez, R Vassena, J Bilić, V Pekarik, et al. (2008). Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26:1276- 1284.
9. Sugii S, Y Kida, WT Berggren and RM Evans. (2011). Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells. Nat Protoc 6:346-358.
10. Seki T, S Yuasa, M Oda, T Egashira, K Yae, D Kusumoto, H Nakata, S Tohyama, H Hashimoto, et al. (2010). Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7:11-14.
11. Eminli S, A Foudi, M Stadtfeld, N Maherali, T Ahfeldt, G Mostoslavsky, H Hock and K Hochedlinger. (2009). Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet 41:968-976.
12. Staerk J, MM Dawlaty, Q Gao, D Maetzel, J Hanna, CA Sommer, G Mostoslavsky and R Jaenisch. (2010). Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 7:20-24.
13. Loh Y, S Agarwal, IH Park, A Urbach, H Huo, GC Heffner, K Kim, JD Miller, K Ng and GQ Daley. (2009). Generation of induced pluripotent stem cells from human blood. Blood 113:5476-5479.
14. Ye Z, H Zhan, P Mali, S Dowey, DM Williams, YY Jang, CV Dang, JL Spivak, AR Moliterno and L Cheng. (2009). Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 114:5473-5480.
15. Haase A, R Olmer, K Schwanke, S Wunderlich, S Merkert, C Hess, R Zweigerdt, I Gruh, J Meyer, et al. (2009). Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 5:434-441.
16. Liu H, Z Ye, Y Kim, S Sharkis and YY Jang. (2010). Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology 51: 1810-1819.
17. Kim JB, H Zaehres, MJ Arauzo-Bravo and HR Scholer. (2009). Generation of induced pluripotent stem cells from neural stem cells. Nat Protoc 4:1464-1470.
18. Utikal J, N Maherali,WKulalert and K Hochedlinger. (2009). Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci 122:3502-3510.
19. Campion DR. (1984). The muscle satellite cell: a review. Int Rev Cytol 87:225-251. (Pubitemid 14141054)
20. Allen RE, CJ Temm-Grove, SM Sheehan and G Rice. (1997). Skeletal muscle satellite cell cultures. Methods Cell Biol 52:155-176. (Pubitemid 128787393)
21. Narsinh K, KH Narsinh and JC Wu. (2011). Derivation of human induced pluripotent stem cells for cardiovascular disease modeling. Circ Res 108:1146-1156.
22. Mali P, BK Chou, J Yen, Z Ye, J Zou, S Dowey, RA Brodsky, JE Ohm, W Yu, et al. (2010). Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells 28:713-720.
23. Li W, W Wei, S Zhu, J Zhu, Y Shi, T Lin, E Hao, A Hayek, H Deng and S Ding. (2009). Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4:16-19.
24. Ory DS, BA Neugeboren and RC Mulligan. (1996). A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A 93:11400-11406. (Pubitemid 26347133)
25. Hussein SM, NN Batada, S Vuoristo, RW Ching, R Autio, E Narva, S Ng, M Sourour, R Hamalainen, et al. (2011). Copy number variation and selection during reprogramming to pluripotency. Nature 471:58-62.
26. Wang Q, X Xu, J Li, J Liu, H Gu, R Zhang, J Chen, Y Kuang, J Fei, et al. (2011). Lithium, an anti-psychotic drug, greatlyenhances the generation of induced pluripotent stem cells. Cell Res 21:1424-1435.
27. Lin T, R Ambasudhan, X Yuan, W Li, S Hilcove, R Abujarour, X Lin, HS Hahm, E Hao, A Hayek and S Ding. (2009). A chemical platform for improved induction of human iPSCs. Nat Methods 6:805-808.
28. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872. (Pubitemid 350138099)
29. Sugii S, Y Kida, T Kawamura, J Suzuki, R Vassena, YQ Yin, MK Lutz, WT Berggren, JC Izpisua Belmonte and RM Evans. (2010). Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells. Proc Natl Acad Sci U S A 107:3558-3563.
30. Nakagawa M, M Koyanagi, K Tanabe, K Takahashi, T Ichisaka, T Aoi, K Okita, Y Mochiduki, N Takizawa and S Yamanaka. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26:101-106.
31. Polo JM, S Liu, ME Figueroa, W Kulalert, S Eminli, KY Tan, E Apostolou, M Stadtfeld, Y Li, et al. (2010). Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol28:848-855.
32. Watanabe S, H Hirai, Y Asakura, C Tastad, M Verma, C Keller, JR Dutton and A Asakura. (2011). MyoD gene suppression by Oct4 is required for reprogramming in myoblasts to produce induced pluripotent stem cells. Stem Cells29:505-516.
33. Mullen AC, DA Orlando, JJ Newman, J Loven, RM Kumar, S Bilodeau, J Reddy, MG Guenther, RP DeKoter and RA Young. (2011). Master transcription factors determine celltype- specific responses to TGF-beta signaling. Cell 147:565- 576.
34. Taberlay PC, TK Kelly, CC Liu, JS You, DD De Carvalho, TB Miranda, XJ Zhou, G Liang and PA Jones. (2011). Polycombrepressed genes have permissive enhancers that initiate reprogramming. Cell 147:1283-1294.
35. Yu J, KF Chau, MA Vodyanik, J Jiang and Y Jiang. (2011). Efficient feeder-free episomal reprogramming with small molecules. PLoS One 6:e17557.
36. Bar-Nur O, HA Russ, S Efrat and N Benvenisty. (2011). Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell 9:17-23.
37. Kim K, A Doi, B Wen, K Ng, R Zhao, P Cahan, J Kim, MJ Aryee, H Ji, et al. (2010). Epigenetic memory in induced pluripotent stem cells. Nature 467:285-290.